ClinConnect ClinConnect Logo
Search / Trial NCT07000916

Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults

Launched by UNIVERSITÉ CATHOLIQUE DE LOUVAIN · May 22, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how to better monitor and manage new cases of certain types of arthritis and autoimmune diseases in children and young adults. The conditions being looked at include juvenile idiopathic arthritis (a common type of arthritis in kids), rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus (a disease that can affect multiple organs), diffuse systemic sclerosis (a condition that causes hardening of the skin), and other related types of arthritis. The trial is currently recruiting participants aged 2 to 50 who have either never received treatment for their condition or have been treated for three months or less.

If you or someone you know is eligible, participants can expect regular check-ups and monitoring to help understand how these conditions progress over time. This study aims to provide valuable information that could lead to better treatments in the future. Remember, this trial is for individuals who are newly diagnosed, so if someone has been treated for more than three months or is over 50 years old, they wouldn't qualify to participate.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of juvenile idiopathic arthritis, rheumatoid arthritis and seronegative / psoriatic / undifferentiated arthritis, systemic lupus erythematosus or diffuse systemic sclerosis (ACR criteria).
  • Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA.
  • Exclusion Criteria:
  • Treated for \> 3 months
  • \> 50 years old

About Université Catholique De Louvain

Université Catholique de Louvain (UCLouvain) is a prestigious Belgian institution renowned for its commitment to academic excellence, research innovation, and interdisciplinary collaboration. With a strong emphasis on advancing medical science and improving patient outcomes, UCLouvain conducts a range of clinical trials across various medical fields. The university's research initiatives are supported by cutting-edge facilities and a team of experienced professionals, fostering a robust environment for clinical investigation. UCLouvain is dedicated to ethical research practices and aims to contribute significantly to the global body of medical knowledge through its clinical trial endeavors.

Locations

Brussels, , Belgium

Patients applied

0 patients applied

Trial Officials

Patrick Durez, Pr

Study Director

UCLouvain - IREC

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported